Immuron

Immuron Limited (IMC) is an oral immunotherapy research and development and product sales focused on bovine-colostrum enriched with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases.

Product sales comprise Travelan and Protectyn, used for the prevention of travellers' diarrhoea.

The group is involved in research & development and hyperimmune products (occur predominantly in Australia, the Unites States and Canada).

Contact Details

03 8892 4854

info@immuron.com

www.immuron.com

Lists and Charts

Share price

Immuron
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
987^th	/Company/iCandy-Interactive	-10.66%	-6.48%
988^th	/Company/Eagers-Automotive	-10.87%	7.77%
989^th	/Company/Immuron	-10.95%	-11.52%
990^th	/Company/Webjet	-11.11%	-8.1%
991^st	/Company/WestStar-Industrial	-11.11%	-13.48%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

Company Activity

	NEW ROLE: Jeannie Joughin, Non-Executive Director	31 Jul 2024
	NEWS: Tagged in Macro share price surges on winds of change	08 Mar 2024
	NEW ROLE: Flavio Palumbo,	30 Oct 2023
	NEW ROLE: Paul Brennan, Non-Executive Director, Non-Executive Chairman	13 Apr 2023
	NEW ROLE: Steven Lydeamore, Chief Executive	03 Nov 2022
	NEW ROLE: Thomas Liquard, Former Chief Executive Officer	24 Nov 2020
	NEW ROLE: Jerry Kanellos, Chief Operating Officer	03 Nov 2020
	NEW ROLE: Roger Aston, Non-Executive Chair	03 Nov 2020
	NEW ROLE: Daniel Pollock, Non-Executive Director	03 Nov 2020

News Articles

Related Information

Access to our data for Immuron is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Immuron is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today